MNDA and lung adenocarcinoma: Hsa-miR-33a-5p, which directly targets myeloid cell nuclear differentiation antigen (MNDA), a member of the hematopoietic protein family, was found to be upregulated in lung adenocarcinoma and was associated with poorer overall survival [40].